Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-03-07

Clinical Trial Update: Efficacy and Safety of Saturno IIB Association on the Control of Ocular Inflammation Post-phacoemulsification [Phase 2]

View source ↗

Summary

A Phase 2 trial update reports efficacy and safety of Saturno IIB association for controlling ocular inflammation after cataract surgery.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Saturno IIB Association

Snippet

Sponsor: EMS | Conditions: Ocular Inflammation, Cataract | Phase 2 | Status: COMPLETED